Invesaro

Stocks Comparison

AdaptHealth vs Chemed: revenue, profit, margins and growth compared

AdaptHealth brought in $3.2B of revenue in fiscal 2025, Chemed $2.5B in fiscal 2025. Revenue changed by -0.5% at AdaptHealth and +4.1% at Chemed on the year before, so Chemed grew faster. AdaptHealth kept -2.2% of its revenue as net profit, Chemed 10.5%. Free cash flow was $219.4M at AdaptHealth and $325.5M at Chemed.

Side by side, latest fiscal year

AHCOCHE
Fiscal year endedFY2025 (December 31, 2025)FY2025 (December 31, 2025)
Revenue$3.2B$2.5B
Revenue growth-0.5%+4.1%
Net income-$70.8M$265.2M
Net margin-2.2%10.5%
Free cash flow$219.4M$325.5M
Free cash flow margin6.8%12.9%
Earnings per share (diluted)-$0.52$18.34
Cash$106.1M$74.5M
Debt$1.7Bn/a
Price to earningsn/a27.9
Market value$769M$6.7B
Dividend yieldn/a0.43%
Rank by revenue in sector#79 of 523 · Health care#95 of 523 · Health care

Over the years

Revenue
AHCO FY2018: $345.3MAHCO FY2019: $529.6MAHCO FY2020: $1.1BAHCO FY2021: $2.5BAHCO FY2022: $3BAHCO FY2023: $3.2BAHCO FY2024: $3.3BAHCO FY2025: $3.2BCHE FY2018: $1.8BCHE FY2019: $1.9BCHE FY2020: $2.1BCHE FY2021: $2.1BCHE FY2022: $2.1BCHE FY2023: $2.3BCHE FY2024: $2.4BCHE FY2025: $2.5BFY18FY19FY20FY21FY22FY23FY24FY25
AHCO $3.2BCHE $2.5B
Net income
AHCO FY2018: $23.3MAHCO FY2019: -$21.3MAHCO FY2020: -$161.6MAHCO FY2021: $156.2MAHCO FY2022: $69.3MAHCO FY2023: -$678.9MAHCO FY2024: $90.4MAHCO FY2025: -$70.8MCHE FY2018: $205.5MCHE FY2019: $219.9MCHE FY2020: $319.5MCHE FY2021: $268.6MCHE FY2022: $249.6MCHE FY2023: $272.5MCHE FY2024: $302MCHE FY2025: $265.2MFY18FY19FY20FY21FY22FY23FY24FY25
AHCO -$70.8MCHE $265.2M
Net margin
AHCO FY2018: 6.7%AHCO FY2019: -4.0%AHCO FY2020: -15.3%AHCO FY2021: 6.4%AHCO FY2022: 2.3%AHCO FY2023: -21.2%AHCO FY2024: 2.8%AHCO FY2025: -2.2%CHE FY2018: 11.5%CHE FY2019: 11.3%CHE FY2020: 15.4%CHE FY2021: 12.6%CHE FY2022: 11.7%CHE FY2023: 12.0%CHE FY2024: 12.4%CHE FY2025: 10.5%FY18FY19FY20FY21FY22FY23FY24FY25
AHCO -2.2%CHE 10.5%
Revenue growth
AHCO FY2019: +53.4%AHCO FY2020: +99.5%AHCO FY2021: +132.4%AHCO FY2022: +21.0%AHCO FY2023: +7.7%AHCO FY2024: +1.9%AHCO FY2025: -0.5%CHE FY2019: +8.7%CHE FY2020: +7.3%CHE FY2021: +2.9%CHE FY2022: -0.2%CHE FY2023: +6.1%CHE FY2024: +7.4%CHE FY2025: +4.1%FY19FY20FY21FY22FY23FY24FY25
AHCO -0.5%CHE +4.1%
Free cash flow
AHCO FY2018: $58.5MAHCO FY2019: $39.1MAHCO FY2020: $155.9MAHCO FY2021: $72.4MAHCO FY2022: -$17.6MAHCO FY2023: $143.2MAHCO FY2024: $235.8MAHCO FY2025: $219.4MCHE FY2018: $234.3MCHE FY2019: $248.2MCHE FY2020: $430.5MCHE FY2021: $249.9MCHE FY2022: $252.6MCHE FY2023: $273.4MCHE FY2024: $368MCHE FY2025: $325.5MFY18FY19FY20FY21FY22FY23FY24FY25
AHCO $219.4MCHE $325.5M

Fiscal years as each company reports them; the two may end in different months.

Questions about AdaptHealth and Chemed

Which is bigger by revenue, AdaptHealth or Chemed?

AdaptHealth is bigger by revenue: $3.2B in fiscal 2025, against $2.5B for Chemed in fiscal 2025.

Which keeps more of its revenue as profit, AdaptHealth or Chemed?

AdaptHealth had a net margin of -2.2% in fiscal 2025; Chemed had 10.5% in fiscal 2025.

Which grew revenue faster, AdaptHealth or Chemed?

In their latest fiscal years revenue changed by -0.5% at AdaptHealth and +4.1% at Chemed.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies